[ Price : $8.95]
Merck announces that the combination of Keytruda (pembrolizumab) and Pfizers Padcev (enfortumab vedotin-ejfv), given before and af...[ Price : $8.95]
A MedDevice Online column says manufacturers can often avoid an FDA Warning Letter by providing an urgent and accountable full res...[ Price : $8.95]
The Guardian reports that the emergency use authorization for Pfizers Covid-19 vaccine for children under five may not be renewed ...[ Price : $8.95]
Vinay Prasad returns as CBER head at FDA commissioner Marty Makarys request after gaining White House approval.[ Price : $8.95]
Novartis says that it will seek FDA approval of its investigational drug ianalumab after it met the primary endpoint in two Phase ...[ Price : $8.95]
FDA accepts for priority review a GSK supplemental NDA for gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoe...[ Price : $8.95]
IO Biotech says its investigational cancer vaccine Cylembio (imsapepimut and etimupepimut, adjuvanted), combined with Mercks Keytr...